| 前收市價 | 2.4000 |
| 開市 | 1.5000 |
| 買盤 | 0.0000 |
| 賣出價 | 2.3500 |
| 拍板 | 10.00 |
| 到期日 | 2024-12-20 |
| 今日波幅 | 1.5000 - 1.5000 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 1 |
InvestorPlace3 Must-Buy Biotech Stocks Before the Summer Rally Kicks Off
Amid the rise of the digital innovation space, investors may want to consider biotech stocks to buy. Fundamentally, a rotation into the sector may occur, boding well for the ecosystem before the summer rally kicks off. It really comes down to investors enjoying gargantuan returns in the technology industry. Yes, artificial intelligence is all the rage but there’s also the concern that the sector has moved too quickly. At the same time, risk-on sentiment appears robust, as evidenced by the contin
ZacksSolid Biosciences (SLDB) Falls Despite FDA Rare Tag for DMD Drug
Solid Biosciences' (SLDB) novel gene-therapy candidate, SGT-003, gets FDA's Rare Pediatric Disease Designation for the treatment of Duchenne muscular dystrophy.
Investor's Business DailyHow Sleeper Biotech Solid Biosciences, With A 687% Gain, Is Making A Comeback
Solid Biosciences is shrugging off several messy years in gene therapy development. The biotech stock has gotten a triple-digit boost.
